Positions
Roswell Park Comprehensive Cancer Center
- Fellow - Hematology and Medical Oncology (Class of 2028)
- Department of Medicine
Background
Education and Training
- 2022 - MD - New York Institute of Technology, College of Osteopathic Medicine
Residency
- 2025 - University at Buffalo, Internal Medicine Residency
Professional Memberships
- American Medical Association (AMA)
- American Osteopathic Association (AOA)
- American College of Physicians (ACP)
- American Society of Clinical Oncology (ASCO)
- American Society of Hematology (ASH)
Professional Experience
- Internal Medicine Residency, University at Buffalo, General Surgery, Chief Resident
- Physician/Armed Forces Officer
Publications
- Azad Farhan, Fekrmandi Fatemeh, Amin Mody, Goulenko Victor, Belal Ahmed, Plunkett Robert, Fabiano Andrew, Fenstermaker Robert, Lipinski Lindsay, Torka Pallawi, Cortese Matthew, Hernandez-Ilizaliturri Francisco, Prasad Dheerendra. (2023). Outcomes of stereotactic radiosurgery in central nervous system lymphoma: A single institution experience. Journal of Clinical Oncology. 41. e14061-e14061. 10.1200/JCO.2023.41.16_suppl.e14061. e14061Parley Fillmore
- Fatemeh Fekrmandi, Farhan Azad, Victor Goulenko, Mody Amin, Ahmed Belal, Robert Plunkett, Andrew Fabiano, Robert Fenstermaker, Lindsay Lipinski, Pallawi Torka, Matthew Cortese, Francisco Hernandez-Ilizaliturri, Dheerendra Prasad Stereotactic radiosurgery as an effective and safe treatment modality in central nervous system lymphoma, a single institution experience. (ASCO 2023)
- Farhan Azad, Fatemeh Fekrmandi, Mody Amin, Victor Goulenko, Katy Wang, Kris Attwood, Dheerendra Prasad, Francisco J. Hernandez-Ilizaliturri Germinal Center B-Cell-like (GCB) Phenotype Predicts Improved Outcomes in Central Nervous System Diffuse Large B-Cell Lymphoma Patients Receiving Stereotactic Radiosurgery (SRS) (ASH 2023)
- Mody Amin, Alex Niu, Kristopher Attwood, Anthony George, Farhan Azad, Jerry Wong, Grant Schofield, Dorothy Pan, Cory Mavis, Sheila Jani Sait, AnneMarie Block, Eugene Przespolewski, Carolyn Connors, Andrea Darrall, Joseph DeMarco, Keryn Gauch, Nikolina Gjorgievski, Michael Johnson, Linda Manth, Kenneth McWhite, Alice Mohr, Matthew Cortese1 Francisco J. Hernandez-Ilizaliturri, Carfilzomib plus Rituximab, Ifosfamide, Carboplatin and Etoposide (CRICE) led to improved outcomes over RICE in Transplant-Eligible Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) (ASCO 2024)
- Mody Amin, Erin Feliciano, Melissa Fos, Tara Cronin, Pamela J Sng, Steven Green, Elizabeth A. Griffiths, Amanda Przespolewski, James E. Thompson, Eunice S. Wang; Impact of Body Mass Index and Karyotype on Clinical Outcomes in Adolescents and Young Adults (AYA) with Acute Myeloid Leukemia. (ASCO 2024)